The gender factor effect for the edocryne function of mesenchymal tissues in children and adolescent
- 作者: Shestopalov A.V.1,2,3, Davydov V.V.4, Tumanyan G.T.5, Savchuk D.V.5, Teplyakova E.D.5, Shin V.F.6, Grigoryeva T.V.7, Laikov A.V.8, Borisenko O.V.4, Roumiantsev S.A.4,2
-
隶属关系:
- Pirogov Russian National Research Medical University, , Russian Federation
- Center of Digital and Translational Biomedicine «Сenter of Molecular Health»
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Pirogov Russian National Research Medical University
- The Rostov State Medical University
- 5The Rostov State Medical University
- Kazan Federal University
- 4Kazan Federal University
- 期: 卷 21, 编号 2 (2023)
- 页面: 52-59
- 栏目: Original research
- URL: https://journals.eco-vector.com/1728-2918/article/view/340881
- DOI: https://doi.org/10.29296/24999490-2023-02-08
- ID: 340881
如何引用文章
详细
Introduction. There is take place increasing in the incidence of obesity among children and adolescents in the world. However, until now there are not exist clear views about mechanisms of that phenomenon.
The aim of study. The purpose of that work is comparative analysis of metabolic status, as well as content of adipokines, myokines and some hormones in the blood of children and adolescents with obesity, dependent of gender.
Methods. Quantification of the adipokines, myokines and hormones was carried out using multiplex ELISA.
Results. Studies have revealed gender differences in the level of certain hormones, adipokines, and myokines, suggesting the appearance of features in the development of obesity in boys and girls. Obese girl experience compensatory changes that help limit manifestation of insulin resistance and lipotoxicity, as well as cardioprotective and neuroprotective effects. This prevents them from serious complications from the cardiovascular and central nervous system in obesity. In boy, due to the formation of gender peculiarities in the production of hormones, adipokines, and myokines, with obesity there are propose for appearance of a number of complications that worse the prognosis of disease in terms of development of its complications – type II diabetes mellitus and atherosclerosis.
Conclusion. The development of obesity in children and adolescents is accompanied by the appearance of gender peculiarities on the part of the endocrine function of mesenchymal tissues.
全文:
![受限制的访问](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
作者简介
Alexander Shestopalov
Pirogov Russian National Research Medical University, , Russian Federation; Center of Digital and Translational Biomedicine «Сenter of Molecular Health»; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
Email: al-shest@yandex.ru
ORCID iD: 0000-0002-1428-7706
Holder of the department of biochemistry and molecular biology, Vice director of the Center of Digital and Translational Biomedicine, Holder of the department of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Doctor of Medical Sci., professor
俄罗斯联邦, Ostrovityanova st., 1, Moscow, 117997; Nakhimovski av., 32, 1, Moscow, 117218; Samory Mashela st., 1, Moscow, 117997Vadim Davydov
Pirogov Russian National Research Medical University
Email: vaddavydov@mail.ru
ORCID iD: 0000-0002-3347-1832
professor of the department of biochemistry and molecular biology, Doctor of Medical Sci., professor
俄罗斯联邦, Ostrovityanova st., 1, Moscow, 117997Genrik Tumanyan
The Rostov State Medical University
Email: henrik1995@mail.ru
ORCID iD: 0000-0002-4428-4477
pediatrian
俄罗斯联邦, Nakhichevansky st., 29, Rostov-na-Donu, 344022Dmitriy Savchuk
The Rostov State Medical University
Email: dr.savchyk@mail.ru
ORCID iD: 0000-0003-0594-3385
pediatrian
俄罗斯联邦, Nakhichevansky st., 29, Rostov-na-Donu, 344022Elena Teplyakova
The Rostov State Medical University
Email: mzro@aaanet.ru
ORCID iD: 0000-0002-3585-7026
professor of the Department of Children’s Diseases, Doctor of Medical Sci.,professor
俄罗斯联邦, Nakhichevansky st., 29, Rostov-na-Donu, 344022Vladimir Shin
5The Rostov State Medical University
Email: shinmz@mail.ru
ORCID iD: 0000-0002-7111-3366
assistant professor of the department of polyclinic and Emergency pediatrics
俄罗斯联邦, Nakhichevansky st., 29, Rostov-na-Donu, 344022Tatiana Grigoryeva
Kazan Federal University
Email: tatabio@inbox.ru
ORCID iD: 0000-0001-5314-7012
leading researcher, Candidate of Biological Sciences
俄罗斯联邦, Kremlyovskaya str., 18, Kazan, 420008Alexander Laikov
4Kazan Federal University
Email: alexander.laikov@yandex.ru
ORCID iD: 0000-0002-4250-2645
researcher
俄罗斯联邦, Kremlyovskaya str., 18, Kazan, 420008Olga Borisenko
Pirogov Russian National Research Medical University
Email: borisenko_olga07@mail.ru
ORCID iD: 0000-0001-8007-6045
assistant professor of the department of biochemistry and molecular biology, Candidate of Biological Sciences
俄罗斯联邦, Ostrovityanova st., 1, Moscow, 117997Sergey Roumiantsev
Pirogov Russian National Research Medical University; Center of Digital and Translational Biomedicine «Сenter of Molecular Health»
编辑信件的主要联系方式.
Email: s_roumiantsev@mail.ru
ORCID iD: 0000-0002-7418-0222
Holder of the department of oncology, hematology and radiation therapy, Director of the Center of Digital and Translational Biomedicine, Holder of the department of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Corresponding member of the Russian Academy of Sciences. Doctor of Medical Sci., professor
俄罗斯联邦, Ostrovityanova st., 1, Moscow, 117997; Nakhimovski av., 32, 1, Moscow, 117218参考
- Weihrauch-Blüher S., Schwarz P., Klusmann J-H. Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood. Metabolism. 2019; 92: 147–52. doi: 10.1016/j.metabol.2018.S.m,12.001
- Li Kheng Chai, Farletti R., Fathi L., Littlewood R. A Rapid Review of the Impact of Family-Based Digital Interventions for Obesity Prevention and Treatment on Obesity-Related Outcomes in Primary School-Aged Children. Nutrients. 2022; 14 (22): 4837–45. doi: 10.3390/nu14224837
- Ronald Kahn C.R., Wang G., Lee K.Y. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J. Clin. Invest. 2019; 129 (10): 3990–4000. doi: 10.1172/JCI129187
- Yuan M., Weidong Li., Yan Zhu, Boyao Yu., Jing Wu. Asprosin: A Novel Player in Metabolic Diseases. Front. Endocrinol. (Lausanne). 2020; 11: 64–72. doi: 10.3389/fendo.2020.00064
- Choe S.S., Huh J.Y., Hwang I.J., Kim J.I., Kim J.B. Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders. Front. Endocrinol. (Lausanne). 2016; 7: 30–7. doi: 10.3389/fendo.2016.00030.
- Fang H., Judd R.L. Adiponectin Regulation and Function. Compr. Physiol. 2018; 8 (3): 1031–63. doi: 10.1002/cphy.c170046
- Aragón-Vela J., Alcalá-Bejarano Carrillo J., Moreno-Racero A., Plaza-Diaz J. The Role of Molecular and Hormonal Factors in Obesity and the Effects of Physical Activity in Children. Int. J. Mol. Sci. 2022; 23 (23): 15413–9. doi: 10.3390/ijms232315413
- Iglesias P., Selgas R., Romero S., DIez J.J. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. Eur. J. Endocrinol. 2012; 167 (3): 301–9. doi: 10.1530/EJE-12-0357
- Pereira S., Cline D.L., Glavas M.M., Covey S.D., Kieffer T.J. Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism. Endocr. Rev. 2021; 42 (1): 1–28. doi: 10.1210/endrev/bnaa027
- Hoffmann J.G., Xie W., Chopra A.R. Energy Regulation Mechanism and Therapeutic Potential of Asprosin. Diabetes. 2020; 64 (4): 559–66. doi: 10.2337/dbi19-0009
- Mazur-Bialy A.I. Asprosin-A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature. Nutrients. 2021; 13 (2): 620–2. doi: 10.3390/nu13020620
- Tripathi D., Kant S., Pandey S., Ehtesham N.Z. Resistin in metabolism, inflammation, and disease. FEBS J. 2020; 287 (15): 3141–9. doi: 10.1111/febs.15322
- Gómez-Banoy N., , Guseh J.S., , Li G., Rubio-Navarro A., Chen T., Poirier B., Putzel G., Rosselot C., Pabón M.A., Camporez J.P., Bhambhani V., Hwang Shih-Jen, Chen Yao, Perry R.J. Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans. Nat. Med. 2019; 25 (11): 1739–47. doi: 10.1038/s41591-019-0610-4
- Shestopalov A.V., Mishra A., Gaponov A.M., Rumyantsev S.A. The Effect of TLR Agonists and Myokines on Secretory Activity of Adipogenically Differentiated MSC Cultures. Вull. Exp. Biol. Med. 2021; 171 (6): 722–6. doi: 10.1007/s10517-021-05303-3 (in Russian).
- Kirk B., Feehan J., Lombardi G., Duque G. Muscle, Bone, and Fat Crosstalk: the Biological Role of Myokines, Osteokines, and Adipokines. Curr. Osteoporos. Rep. 2020; 18 (4): 388–400. doi: 10.1007/s11914-020-00599-y
- Stanford K.I., Goodyear L.J. Muscle-Adipose Tissue Cross Talk. Cold Spring Harb. Perspect. Med. 2018; 8 (8): a029801. doi: 10.1101/cshperspect.a029801.
- Milek M., Moulla Y., Kern M., Stroh C., Dietrich A., Schön M.R., Gärtner D., Lohmann T., Dressler M., Kovac P., Stumvoll M., Blüher M., Guiu-Jurado E. Adipsin Serum Concentrations and Adipose Tissue Expression in People with Obesity and Type 2 Diabetes. Int. J. Mol. Sci. 2022; 23 (4): 2222–9. doi: 10.3390/ijms23042222
- Shin K., Pandey A., Xiang-Qin Liu, Anini Y., Rainey J.K. Preferential apelin-13 production by the proprotein convertase PCSK3 is implicated in obesity. FEBS Open Bio. 2013; 3: 328–33. doi: 10.1016/j.fob.2013.08.001
- Hak A.E., Pols A., Visser T.J. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann. Intern. Med. 2000; 132 (4): 270–8.
- Sridevi A., Vivekanand B., Giridhar G., Mythili A., Subrahmanyan K.A. Insulin resistance and lipid alterations in subclinical hypothyroidism. Indian J. Endocrinol. Metab. 2012; 16 (2): 345–6.
- Marczewski K., Gospodarczyk N., Gospodarczyk A., Widuch M., Tkocz M. Apelin in heart failure. Wiad. Lek. 2022; 75 (10): 2501–6. doi: 10.36740/WLek202210130
- Ji M., Zuo Z., Zhang M., Xu Z., Hu G. Osteocrin alleviates cardiac hypertrophy via attenuating oxidative stress. Peptides. 2022; 15: 170773. doi: 10.1016/j.peptides.2022.170773
- Ataman, B., Boulting, G., Harmin, D. Evolution of Osteocrin as an activity-regulated factor in the primate brain. Nature. 2016; 539: 242–7. DOI: org/10.1038/nature20111
补充文件
![](/img/style/loading.gif)